BioMark Diagnostics Inc.
BioMark Diagnostics Inc. (BUX.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BUX.CN · as of Jun 9, 2026
Key Statistics
Explore BioMark Diagnostics Inc. Data
bux.cn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bux.cn competitorsBUX.CN
ADK.V
AVCN.TO
CWEB.TO
GLAB.CN
IZO.CNStock Performance
Full HistoryAbout BioMark Diagnostics Inc.
BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment ef…
what is biomark diagnostics inc. · bux.cn stock overview · biomark diagnostics inc. company profile · who is biomark diagnostics inc. ceo · bux.cn CNQ · biomark diagnostics inc. headquarters · biomark diagnostics inc. business segments
About Stock Overview & Key Data
BioMark Diagnostics Inc. (BUX.CN) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on CNQ since Nov 3, 2014. As of the latest trading session, BUX.CN stock price is $0.56, with a market capitalization of $58.9M. The stock has returned +80.65% over the past 12 months and +19.15% year-to-date.
In fiscal year 2025, BioMark Diagnostics Inc. reported revenue of $154216.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioMark Diagnostics Inc. (BUX.CN) stock price is $0.56. The stock is traded on CNQ under the ticker symbol BUX.CN. The 52-week range is $0.27 – $0.64.